Clinical pathway for acute exacerbations of chronic obstructive pulmonary disease: Method development and five years of experience

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 365-372

  Nishimura, Koichi ^a   Yasui, Maya ^b   Nishimura, Takashi ^b   Oga, Toru ^c  

^a Department of Internal Medicine   (Japan)

^b KYOTO KATSURA HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

AECOPD; COPD; Mortality; Pulmonary rehabilitation

Indexed keywords

ACUTE DISEASE; ADVERSE OUTCOME; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PATHWAY; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HOSPITALIZATION; HUMAN; JAPAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; RESPIRATORY TRACT INTUBATION; THERAPY EFFECT; DECISION SUPPORT SYSTEM; ENDOTRACHEAL INTUBATION; GENERAL HOSPITAL; HEALTH CARE QUALITY; HOSPITAL PATIENT; LUNG; LUNG FUNCTION TEST; MORTALITY; PATHOPHYSIOLOGY; PATIENT; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; STANDARD; TIME; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ADRENAL CORTEX HORMONES; AGED; ANTI-BACTERIAL AGENTS; BRONCHODILATOR AGENTS; CRITICAL PATHWAYS; DECISION SUPPORT TECHNIQUES; FEMALE; HOSPITAL MORTALITY; HOSPITALS, GENERAL; HUMANS; INPATIENTS; INTUBATION, INTRATRACHEAL; JAPAN; LENGTH OF STAY; LUNG; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); OXYGEN INHALATION THERAPY; PATIENT DROPOUTS; POSITIVE-PRESSURE RESPIRATION; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 81055123893     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S20423     Document Type: Article

References (22)

1. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6): 532-555.
2. Price LC, Lowe D, Hosker HS, et al. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax. 2006; 61(10):837-842.
3. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894-903.
4. Mularski RA, Asch SM, Shrank WH, et al. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest. 2006;130(6):1844-1850.
5. Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316(7125):133-137.
6. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9(4):458-465.
7. Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009(1):CD005305.
8. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61-65.
9. Lieberman D, Lieberman D, Gelfer Y, et al. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest. 2002;122(4): 1264-1270.
10. Calverley PM. Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(2): 121-124.
11. Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modifcation in COPD. Patient Educ Couns. 2004;52(3):271-277.
12. Lemmens KM, Nieboer A P, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103(5):670-691.
13. Wesseling G, Vrijhoef H. Acute exacerbations of COPD: recommendations for integrated care. Expert Rev Resp Med. 2008;2(4):489-494.
14. Liaaen ED, Henriksen AH, Stenfors N. A Scandinavian audit of hospitalizations for chronic obstructive pulmonary disease. Respir Med. 2010;104(9):1304-1309.
15. Stein BD, Charbeneau JT, Lee TA, et al. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD. 2010;7(3):164-171.
16. Nishimura K. Lung health in Japan. Chron Respir Dis. 2006;3(2): 104-105.
17. Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive-pressure ventilation in acute respiratory failure outside clinical trials: experience at the Massachusetts General Hospital. Crit Care Med. 2008;36(2): 441-447.
18. Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Arch Phys Med Rehabil. 1998;79(7):849-854.
19. Eaton T, Young P, Fergusson W, et al. Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology. 2009;14(2):230-238.
20. Troosters T, Probst VS, Crul T, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(10):1072-1077.
21. Mitchell EA, Didsbury PB, Kruithof N, et al. A randomized controlled trial of an asthma clinical pathway for children in general practice. Acta Paediatr. 2005;94(2):226-233.
22. Wazeka A, Valacer DJ, Cooper M, Caplan DW, DiMaio M. Impact of a pediatric asthma clinical pathway on hospital cost and length of stay. Pediatr Pulmonol. 2001;32(3):211-216.